Year archive

OPKO Health Inc. — 2022 filings

All 190 regulatory filings released by OPKO Health Inc. (OPK) in 2022, sourced directly from the official regulator.

190 Filings

2022 Period

2022 filings (190)

Filing	Released	Lang
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-PHILLIP M.D. ET AL Director's Dealing	2022-11-23	English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-PHILLIP M.D. ET AL Report Publication Announcement	2022-11-23	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- PROST PHILLIP Director's Dealing	2022-11-10	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- PROST PHILLIP Report Publication Announcement	2022-11-10	English
FORM 10-Q: 2022 Third Quarter Financial report Interim / Quarterly Report 9M 2022	2022-11-09	English
FORM 10-Q: 2022 Third Quarter Financial report Report Publication Announcement Q3 2022	2022-11-09	English
2022 Third Quarter Business Highlights and Financial Earnings Release Q3 2022	2022-11-09	English
2022 Third Quarter Business Highlights and Financial Report Publication Announcement	2022-11-09	English
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022 Earnings Release 9M 2022	2022-11-01	English
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022 Report Publication Announcement	2022-11-01	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-10-30	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Legal Proceedings Report	2022-10-30	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-10-20	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-10-20	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET AL Director's Dealing	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET A Director's Dealing	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET A Report Publication Announcement	2022-10-18	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET AL Director's Dealing	2022-10-11	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-10-11	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Major Shareholding Notification	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Report Publication Announcement	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-09-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-09-21	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-09-21	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-09-20	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-09-20	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Report Publication Announcement	2022-09-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Director's Dealing	2022-09-17	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- FROST PHILLIP Major Shareholding Notification	2022-09-06	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- FROST PHILLIP Legal Proceedings Report	2022-09-06	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- .Hsu Gamma Investments, LP, Jane H. Hsiao, Ph.D Major Shareholding Notification	2022-08-20	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- .Hsu Gamma Investments, LP, Jane H. Hsiao, Ph.D Regulatory Filings	2022-08-20	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FROST GROUP - 13D/A Major Shareholding Notification	2022-08-20	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FROST GROUP - 13D/A Report Publication Announcement	2022-08-20	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP-FORM 4 Director's Dealing	2022-08-20	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP-FORM 4 Report Publication Announcement	2022-08-20	English
Leadership Changes for BioReference Laboratories Regulatory Filings	2022-08-17	English
Leadership Changes for BioReference Laboratories Regulatory Filings	2022-08-17	English
Leadership Changes for BioReference Laboratories Board/Management Information	2022-08-17	English
Leadership Changes for BioReference Laboratories Report Publication Announcement	2022-08-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-08-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-08-08	English
FORM 8-K-Reports 2022 Second Quarter Business Highlights and Financial Results Earnings Release Q2 2022	2022-08-06	English
FORM 8-K-Reports 2022 Second Quarter Business Highlights and Financial Results Report Publication Announcement	2022-08-06	English
Form 10-Q-Second quarter 2022 financial results Interim / Quarterly Report Q2 2022	2022-08-04	English
Form 10-Q-Second quarter 2022 financial results Report Publication Announcement Q2 2022	2022-08-04	English
Reports 2022 Second Quarter Business Highlights and Financial Results Earnings Release Q2 2022	2022-08-04	English
Reports 2022 Second Quarter Business Highlights and Financial Results Earnings Release Q2 2022	2022-08-04	English
to Report Second Quarter 2022 Financial Results and a conference call on August 4, 2022 at 4:30pm Report Publication Announcement	2022-07-26	English
to Report Second Quarter 2022 Financial Results and a conference call on August 4, 2022 at 4:30pm Report Publication Announcement	2022-07-26	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing Report Publication Announcement	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C Regulatory Filings	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A Paganelli John A Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A Paganelli John A Regulatory Filings	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Medel, M.D. Roger J. Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Medel, M.D. Roger J. Report Publication Announcement	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Lachman, M.D. Prem A. Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Lachman, M.D. Prem A. Regulatory Filings	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Krasno, Ph,D. Richard M. Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Krasno, Ph,D. Richard M. Report Publication Announcement	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis - Director's Dealing	2022-07-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis - Report Publication Announcement	2022-07-17	English
Entry into a Material Definitive Agreement., Annual meeting results Regulatory Filings	2022-07-17	English
Entry into a Material Definitive Agreement., Annual meeting results Report Publication Announcement	2022-07-17	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Gary J. Nabel, M.D., Ph.D.-13D Major Shareholding Notification	2022-06-29	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Gary J. Nabel, M.D., Ph.D.-13D Regulatory Filings	2022-06-29	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Elias A. Zerhouni, M.D-13D Major Shareholding Notification	2022-06-29	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Elias A. Zerhouni, M.D-13D Regulatory Filings	2022-06-29	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-Nabel, M.D Ph.D Gary Director's Dealing	2022-06-25	English
CANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-Nabel, M.D Ph.D Gary Report Publication Announcement	2022-06-25	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D Ph.D Gary J Director's Dealing	2022-06-23	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D Ph.D Gary J Director's Dealing	2022-06-23	English
form 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Zerhouni, M.D. Elias A. Director's Dealing	2022-06-23	English
form 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES -Zerhouni, M.D. Elias A. Director's Dealing	2022-06-23	English
FORM 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Director's Dealing	2022-06-22	English
FORM 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Regulatory Filings	2022-06-22	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Regulatory Filings	2022-06-19	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Report Publication Announcement	2022-06-19	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-06-14	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-06-14	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-06-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Report Publication Announcement	2022-06-08	English
Annual Meetung at July 14, 2022 Proxy Solicitation & Information Statement	2022-06-05	English
Annual Meetung at July 14, 2022 Proxy Solicitation & Information Statement	2022-06-05	English
NOTICE OF 2022 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JULY 14, 2022 Proxy Solicitation & Information Statement	2022-06-05	English
NOTICE OF 2022 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JULY 14, 2022 AGM Information	2022-06-05	English
Present at the 2022 Jefferies Healthcare Conference Regulatory Filings	2022-06-02	English
Present at the 2022 Jefferies Healthcare Conference Report Publication Announcement	2022-06-02	English
CHANGES IN BENEFICIAL OWNERSHIP- PHILLIP M.D.ET AL Director's Dealing	2022-06-02	English
CHANGES IN BENEFICIAL OWNERSHIP- PHILLIP M.D.ET AL Regulatory Filings	2022-06-02	English
FORM 4 -STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-06-01	English
FORM 4 -STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Regulatory Filings	2022-06-01	English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-FROST PHILLIP Director's Dealing	2022-05-26	English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-FROST PHILLIP Report Publication Announcement	2022-05-26	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary J Director's Dealing	2022-05-21	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary J Report Publication Announcement	2022-05-21	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROM 4- FROST PHILLIP Director's Dealing	2022-05-19	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROM 4- FROST PHILLIP Regulatory Filings	2022-05-19	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Report Publication Announcement	2022-05-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Director's Dealing	2022-05-16	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Report Publication Announcement	2022-05-16	English
Entry into a Material Definitive Agreement. Regulatory Filings	2022-05-15	English
Entry into a Material Definitive Agreement. Report Publication Announcement	2022-05-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis Director's Dealing	2022-05-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis Report Publication Announcement	2022-05-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Regulatory Filings	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nabel, M.D., Ph.D Gary Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-12	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-12	English
FORM 3- BENEFICIAL OWNERSHIP OF SECURITIES- Zerhouni, M.D.Elias A. Director's Dealing	2022-05-12	English
FORM 3- BENEFICIAL OWNERSHIP OF SECURITIES- Zerhouni, M.D.Elias A. Director's Dealing	2022-05-12	English
BENEFICIAL OWNERSHIP OF SECURITIES- Nabel, M.D., Ph.D Gary J. Director's Dealing	2022-05-12	English
BENEFICIAL OWNERSHIP OF SECURITIES- Nabel, M.D., Ph.D Gary J. Director's Dealing	2022-05-12	English
BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis Director's Dealing	2022-05-12	English
BENEFICIAL OWNERSHIP OF SECURITIES-Borisy Alexis Director's Dealing	2022-05-12	English
FORM 4-CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Director's Dealing	2022-05-11	English
FORM 4-CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Report Publication Announcement	2022-05-11	English
Form 10-Q -First quarter 2022 financial results Interim / Quarterly Report Q1 2022	2022-05-09	English
Form 10-Q -First quarter 2022 financial results Report Publication Announcement	2022-05-09	English
Schedule13D- company's holdings in Sema4 Major Shareholding Notification	2022-05-09	English
Schedule13D- company's holdings in Sema4 Regulatory Filings	2022-05-09	English
FORM 3 - NITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Major Shareholding Notification	2022-05-09	English
FORM 3 - NITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-05-09	English
FORM 8-K- OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results, Conference call begins at 4:30 p.m. Eastern time today Earnings Release Q1 2022	2022-05-09	English
FORM 8-K- OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results, Conference call begins at 4:30 p.m. Eastern time today Report Publication Announcement	2022-05-09	English
OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results Earnings Release Q1 2022	2022-05-09	English
OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results Earnings Release Q1 2022	2022-05-09	English
OPKO acquired ModeX for $300 million in OPKO common stock Regulatory Filings	2022-05-09	English
OPKO acquired ModeX for $300 million in OPKO common stock Report Publication Announcement	2022-05-09	English
OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022 Report Publication Announcement	2022-05-05	English
OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022 Report Publication Announcement	2022-05-05	English
8K: BioReference Laboratories, Inc, a subsidiary entered into a waiver and amendment credit agreement Regulatory Filings	2022-05-05	English
8K: BioReference Laboratories, Inc, a subsidiary entered into a waiver and amendment credit agreement Regulatory Filings	2022-05-05	English
FORM 10-K Amendment No. 1 Annual Report FY 2021	2022-05-03	English
FORM 10-K Amendment No. 1 Report Publication Announcement FY 2021	2022-05-03	English
Sema4 Announces the Completion of the GeneDx Acquisition Board/Management Information	2022-05-02	English
Sema4 Announces the Completion of the GeneDx Acquisition Report Publication Announcement	2022-05-02	English
FORM 8-K - bonus payment, annual salary Board/Management Information	2022-04-28	English
FORM 8-K - bonus payment, annual salary Report Publication Announcement	2022-04-28	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Director's Dealing	2022-03-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Regulatory Filings	2022-03-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Director's Dealing	2022-03-14	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP Report Publication Announcement	2022-03-14	English
Annual Report on Form 10-K for the year ended December 31, 2021 Annual Report FY 2021	2022-03-01	English
Annual Report on Form 10-K for the year ended December 31, 2021 Report Publication Announcement FY 2021	2022-03-01	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Major Shareholding Notification	2022-03-01	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL Regulatory Filings	2022-03-01	English
FROM 4-CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Director's Dealing	2022-02-28	English
FROM 4-CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP M.D. ET AL Regulatory Filings	2022-02-28	English
8K: OPKO Health, Inc. issued a press release announcing operating and financial highlights for the quarter ended December 31, 2021 Earnings Release Q4 2021	2022-02-25	English
8K: OPKO Health, Inc. issued a press release announcing operating and financial highlights for the quarter ended December 31, 2021 Report Publication Announcement Q4 2021	2022-02-25	English
Reports 2021 Fourth Quarter Business Highlights and Financial Results Earnings Release Q4 2021	2022-02-25	English
Reports 2021 Fourth Quarter Business Highlights and Financial Results Earnings Release Q4 2021	2022-02-25	English
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022‎ Earnings Release Q4 2021	2022-02-17	English
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022‎ Report Publication Announcement	2022-02-17	English
Pfizer and OPKO’s Once-Weekly NGENLATM (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency Regulatory Filings	2022-02-15	English
Pfizer and OPKO’s Once-Weekly NGENLATM (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency Report Publication Announcement	2022-02-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-02-15	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Report Publication Announcement	2022-02-15	English
RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP Regulatory Filings	2022-02-03	English
RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP Report Publication Announcement	2022-02-03	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- FROST PHILLIP M.D. Director's Dealing	2022-02-02	English
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4- FROST PHILLIP M.D. Regulatory Filings	2022-02-02	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2022-01-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Report Publication Announcement	2022-01-27	English
Dr. Robert Fishel retiring from service on the Company’s Board of Directors Board/Management Information	2022-01-24	English
Dr. Robert Fishel retiring from service on the Company’s Board of Directors Report Publication Announcement	2022-01-24	English
APAN’S MHLW APPROVES PFIZER AND OPKO’S NGENLA® (SOMATROGON), A NEW LONG-ACTING TREATMENT FOR PEDIATRIC GROWTH HORMONE DEFICIENCY Regulatory Filings	2022-01-20	English
APAN’S MHLW APPROVES PFIZER AND OPKO’S NGENLA® (SOMATROGON), A NEW LONG-ACTING TREATMENT FOR PEDIATRIC GROWTH HORMONE DEFICIENCY Report Publication Announcement	2022-01-20	English
8K-an Agreement and Plan of Merger with Sema4 Holdings Regulatory Filings	2022-01-19	English
8K-an Agreement and Plan of Merger with Sema4 Holdings Report Publication Announcement	2022-01-19	English
Sema4 to Acquire GeneDx, Strengthening its MarketLeading AI-Driven Genomic and Clinical Data Platform M&A Activity	2022-01-18	English
Sema4 to Acquire GeneDx, Strengthening its MarketLeading AI-Driven Genomic and Clinical Data Platform Report Publication Announcement	2022-01-18	English
OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference Report Publication Announcement	2022-01-06	English
OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference Report Publication Announcement	2022-01-06	English

Filings by year

2026 42 filings
2025 141 filings
2024 206 filings
2023 126 filings
2022 190 filings
2021 167 filings
2020 214 filings
2019 346 filings
2018 314 filings
2017 444 filings
2016 470 filings
2015 451 filings
2014 471 filings
2013 198 filings